Aug 7 (Reuters) - Kazia Therapeutics Ltd KZA.AX :
* US FDA GRANTS RARE PEDIATRIC DISEASE DESIGNATION TO PAXALISIB FOR DIFFUSE INTRINSIC PONTINE GLIOMA
Aug 7 (Reuters) - Kazia Therapeutics Ltd KZA.AX :
* US FDA GRANTS RARE PEDIATRIC DISEASE DESIGNATION TO PAXALISIB FOR DIFFUSE INTRINSIC PONTINE GLIOMA